| Literature DB >> 11969361 |
Seitaro Okamura1, Shingo Ameshima, Yoshiki Demura, Takeshi Ishizaki, Shigeru Matsukawa, Isamu Miyamori.
Abstract
To provide evidence that pulmonary endothelial cells exposed to 9,10-epoxy-12-octadecenoate (Lx) produce nitric oxide (NO) and superoxide anion (O(2)(*-), we measured NO production, using a NO chemiluminescence analyzer, and nitric oxide synthase (NOS) activity, monitoring the conversion of L- [14C] arginine to L- [14C] citrulline, and O(2)(*-) by a fluorescence assay using a fluorescence spectrophotometer with hydroethidine (HE) in human pulmonary artery endothelial cells (HPAEC). NO production and eNOS were increased significantly when HPAEC were incubated with 10 microM Lx, and this effect was inhibited by L-NMMA or in the absence of extracellular Ca2+. Addition of 10 mM HE to the cell suspension spontaneously and continuously caused a subtle increase in fluorescence intensity, due to intracellular oxidation of HE to ethidium bromide (EB). Treatment of the cell suspension with Lx after the addition of HE exerted a dose-dependent increase in intracellular EB fluorescence. Pre-treatment with allopurinol, a xanthine oxidase inhibitor, decreased the intracellular EB fluorescence by 54% in HPAEC incubated with 100 microM Lx. These results show that Lx induces NO production via activation of eNOS and O(2)(*-) production in endothelial cells via activation of cellular xanthine oxidase. Thus, Lx is a bioactive lipid. Copyright 2002 Elsevier Science Ltd.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11969361 DOI: 10.1006/pupt.2001.0322
Source DB: PubMed Journal: Pulm Pharmacol Ther ISSN: 1094-5539 Impact factor: 3.410